Drug
Las 41004
Las 41004: highest development phase Phase 2, developed by Almirall. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Almirall
Trials
| Drug | Phase | Indication |
|---|---|---|
| LAS 41004 NCT01119339 | Phase 2 | Psoriasis |
Latest
No recent events.
Follow Las 41004 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.